Filtros de búsqueda

Lista de obras de Véronique Trillet-Lenoir

Adherence to oral anticancer chemotherapy: What influences patients' over or non-adherence? Analysis of the OCTO study through quantitative-qualitative methods

artículo científico publicado en 2015

Assessment of the prognostic role of a 94-single nucleotide polymorphisms risk score in early breast cancer in the SIGNAL/PHARE prospective cohort: no correlation with clinico-pathological characteristics and outcomes

artículo científico publicado en 2017

Concomitant drugs with low risks of drug-drug interactions for use in oncology clinical trials

artículo científico publicado en 2015

Constitutional variants are not associated with HER2-positive breast cancer: results from the SIGNAL/PHARE clinical cohort

artículo científico publicado en 2017

Expression of young HERV-H loci in the course of colorectal carcinoma and correlation with molecular subtypes

artículo científico publicado en 2015

First epidemiological data from the French Trophoblastic Disease Reference Center

artículo científico publicado en 2007

First-in-human phase 1 of YS110, a monoclonal antibody directed against CD26 in advanced CD26-expressing cancers

artículo científico publicado en 2017

GWAS in the SIGNAL/PHARE clinical cohort restricts the association between the FGFR2 locus and estrogen receptor status to HER2-negative breast cancer patients

artículo científico publicado en 2016

Improving cancer patient care with combined medication error reviews and morbidity and mortality conferences

artículo científico publicado en 2013

Oral vinorelbine: role in the management of metastatic breast cancer

artículo científico publicado en 2007

Pharmacokinetically based estimation of patient compliance with oral anticancer chemotherapies: in silico evaluation

artículo científico publicado en 2009

Phase II study of oral vinorelbine in combination with capecitabine as second line chemotherapy in metastatic breast cancer patients previously treated with anthracyclines and taxanes

scientific article published on 09 August 2009

What is the best protocol of single-agent methotrexate chemotherapy in nonmetastatic or low-risk metastatic gestational trophoblastic tumors? A review of the evidence

artículo científico publicado en 2006

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda